Capital Guardian Trust’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
– Sell
-1,900
Closed -$136K – 701
2016
Q1
$136K Sell
1,900
-5,600
-75% -$376K ﹤0.01% 359
2015
Q4
$534K Sell
7,500
-104,900
-93% -$7.05M ﹤0.01% 282
2015
Q3
$6.91M Sell
112,400
-47,800
-30% -$3.34M 0.06% 186
2015
Q2
$11.6M Sell
160,200
-14,300
-8% -$1.06M 0.08% 175
2015
Q1
$13.4M Sell
174,500
-136,900
-44% -$9.8M 0.1% 163
2014
Q4
$20.9M Sell
311,400
-2,645
-0.8% -$167K 0.14% 137
2014
Q3
$19.1M Sell
314,045
-12,155
-4% -$749K 0.14% 136
2014
Q2
$19.1M Buy
326,200
+27,600
+9% +$1.62M 0.13% 138
2014
Q1
$17.3M Buy
298,600
+40,800
+16% +$2.19M 0.12% 141
2013
Q4
$13.8M Buy
257,800
+16,200
+7% +$961K 0.09% 150
2013
Q3
$14.9M Buy
+241,600
New +$14.5M 0.1% 141

Other funds holding DGX

Capital Guardian Trust's DGX Position: Q2 2016 in Review

Capital Guardian Trust sold out of Quest Diagnostics (DGX) in Q2 2016, closing a stake of 1,900 shares — an estimated $136K sold.

Capital Guardian Trust first reported a position in DGX in Q3 2013 and held it in 11 quarters. The position peaked at $20.9M in Q4 2014. 558 funds tracked by Wall St. Rank hold DGX as of Q2 2016.

  • Capital Guardian Trust reported no remaining Quest Diagnostics position as of Q2 2016 after selling out during the quarter.
  • Capital Guardian Trust sold 1,900 Quest Diagnostics shares in Q2 2016, an estimated $136K.
  • Capital Guardian Trust first reported a position in Quest Diagnostics in Q3 2013 and held it in 11 quarters.
  • Capital Guardian Trust's Quest Diagnostics position peaked at $20.9M in Q4 2014.
  • 558 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2016.

Based on Capital Guardian Trust's 13F filing for Q2 2016, filed 15 Aug 2016.